SCI Pharmtech, Inc.

NT$49.55As of Sun 8 Nov 2026, 12:00 UTC
TWSE:4119Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 0.61%
Div yield 1.51%
ROE 1.12%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.04
PE TTM 99.02
TSR TTM (12.51%)
Mkt cap NT$5.922B
ROIC 1.29%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$53
6.65%
(10.76%)
Hold 4|11|9|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.60
0.64
0.67
0.68
15.64%
22.37%
16.81%
18.15%
RevenueNT$M
405.6
410.6
407.2
416.0
4.06%
(0.60%)
(2.27%)
1.03%
Peers (US$178.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.249
0.564
0.492
EBIT/Intx
0.421
0.959
0.940
Own earn%
5.02
(157.77)
(137.17)
Sh yield%
18.24
46.35
43.87
Owners
Insiders/Inst%
9.80
56.42
Short interest%
2.27
SBC / revenue%
1.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
19–27
$1 testx
−0.4
Incr. ROIC%
7